7 results
8-K
EX-99.1
NKTX
Nkarta Inc
25 Mar 24
Regulation FD Disclosure
6:05am
not constitute an offer or solicitation for the sale or purchase of the securities, assets or business described herein or a commitment of the company
8-K
EX-99.1
NKTX
Nkarta Inc
21 Mar 24
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
4:15pm
for their commitment and trust.”
NKX019 in autoimmune disease
In October 2023, Nkarta announced the expansion of its pipeline to include autoimmune disease
8-K
EX-99.1
NKTX
Nkarta Inc
9 Nov 23
Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:06pm
maintain our commitment to developing novel cell therapies for patients with cancer, we are also strongly encouraged by the prospect of NK cell-based
10-Q
2020 Q2
EX-10.6
NKTX
Nkarta Inc
20 Aug 20
Quarterly report
4:51pm
/Service Commitment.
The vesting schedule applicable to the Option requires continued employment or service through each applicable vesting date … or under the Plan.
Nothing contained in this Option Agreement or the Plan constitutes a continued employment or service commitment by the Corporation
10-Q
2020 Q2
EX-10.5
NKTX
Nkarta Inc
20 Aug 20
Quarterly report
4:51pm
of the Code.
Continuance of Board Service Required; No Service Commitment.
The vesting schedule requires the Director’s continued service on the Board … the Plan. Nothing contained in this Option Agreement or the Plan constitutes a continued service commitment by the Corporation or interferes
8-K
EX-3.2
qlripigs5 kb4lvx9vm2
14 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:10pm
S-1/A
EX-3.4
ivbk0fnu d2yq89f08w
2 Jul 20
IPO registration (amended)
5:17pm
- Prev
- 1
- Next